다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of clinical medicine, v.10 no.22, 2021년, pp.5388 -
Fiedorowicz, Ewa (Department of Biochemistry, Faculty of Biology and Biotechnology, University of Warmia and Mazury, Oczapowskiego 1A Street, 10-719 Olsztyn, Poland) , Cieślińska, Anna (ewa.kuzbida@uwm.edu.pl (E.F.)) , Kuklo, Patrycja (anna.cieslinska@uwm.edu.pl (A.C.)) , Grzybowski, Andrzej (Department of Biochemistry, Faculty of Biology and Biotechnology, University of Warmia and Mazury, Oczapowskiego 1A Street, 10-719 Olsztyn, Poland)
AI-Helper
Glaucoma is a multifactorial disease. Early diagnosis of this disease can support treatment and reduce the effects of pathophysiological processes. A significant problem in the diagnosis of glaucoma is limited access to the tested material. Therefore, intensive research is underway to develop biomar...
1. Tuulonen A. Airaksinen P.J. Erola E. Forsman E. Friberg K. Kaila M. Klemetti A. Mäkelä M. Oskala P. Puska P. The Finnish evidence-based guideline for open angle glaucoma Acta Ophthalmol. Scand. 2003 81 3 18 10.1034/j.1600-0420.2003.00021.x 12631014
2. Shon K. Wollstein G. Schuman J.S. Sung K.R. Prediction of glaucomatous field progression: Pointwise analysis Curr. Eye Res. 2014 39 705 710 10.3109/02713683.2013.867353 24892993
3. Weinreb R.N. Khaw P.T. Primary open-angle glaucoma Lancet 2004 363 1711 1720 10.1016/S0140-6736(04)16257-0 15158634
4. Rudnicka A.R. Mt-Isa S. Owen C.G. Cook D.G. Ashby D. Variations in primary open-angle glaucoma prevalence by age, gender, and race: A Bayesian meta-analysis Invest Ophthalmol. Vis. Sci. 2006 47 4254 4261 10.1167/iovs.06-0299 17003413
5. EGS Foundation European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition—Part 1. Supported by the EGS Foundation Br. J. Ophthalmol. 2017 101 1 72 10.1136/bjophthalmol-2016-EGSguideline.001
6. Nakabayashi M. Review of the ischemia hypothesis for ocular hypertension other than congenital glaucoma and closed-angle glaucoma Ophthalmologica 2004 218 344 349 10.1159/000079477 15334016
7. Tezel G. The immune response in glaucoma: A perspective on the roles of oxidative stress Exp. Eye Res. 2011 93 178 186 10.1016/j.exer.2010.07.009 20709058
8. Shazly T.A. Aljajeh M. Latina M.A. Autoimmune basis of glaucoma Semin. Ophthalmol. 2011 26 278 281 10.3109/08820538.2011.588649 21958174
9. Tezel G. A proteomics view of the molecular mechanisms and biomarkers of glaucomatous neurodegeneration Prog. Retin. Eye Res. 2013 35 18 43 10.1016/j.preteyeres.2013.01.004 23396249
10. Soto I. Howell G.R. The complex role of neuroinflammation in glaucoma Cold Spring Harb. Perspect. Med. 2014 4 1 15 10.1101/cshperspect.a017269
11. Chidlow G. Wood J.P.M. Casson R.J. Investigations into hypoxia and oxidative stress at the optic nerve head in a rat model of glaucoma Front. Neurosci. 2017 11 1 22 10.3389/fnins.2017.00478 28154520
12. Quigley H.A. Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020 Br. J. Ophthalmol. 2006 90 262 267 10.1136/bjo.2005.081224 16488940
13. Tezel G. Yang X. Luo C. Kain A.D. Powell D.W. Kuehn M.H. Kaplan K.J. Oxidative stress and the regulation of complement activation in human glaucoma Invest. Ophthalmol. Vis. Sci. 2010 51 5071 5082 10.1167/iovs.10-5289 20484586
14. Yanagi M. Kawasaki R. Wang J.J. Wong T.Y. Crowston J. Kiuchi Y. Vascular risk factors in glaucoma: A review Clin. Exp. Ophthalmol. 2011 39 252 258 10.1111/j.1442-9071.2010.02455.x 20973906
15. Bell K. Gramlich O.W. Von Thun Und Hohenstein-Blaul N. Beck S. Funke S. Wilding C. Pfeiffer N. Grus F.H. Does autoimmunity play a part in the pathogenesis of glaucoma? Prog. Retin. Eye Res. 2013 36 199 216 10.1016/j.preteyeres.2013.02.003 23541978
16. Grzybowski A. Och M. Kanclerz P. Leffler C. De Moraes C.G. Primary open angle glaucoma and vascular risk factors: A review of population based studies from 1990 to 2019 J. Clin. Med. 2020 9 761 10.3390/jcm9030761
17. McMonnies C.W. Glaucoma history and risk factors J. Optom. 2017 10 71 78 10.1016/j.optom.2016.02.003 27025415
18. Hohenstein-Blaul N.V.T.U. Kunst S. Pfeiffer N. Grus F.H. Biomarkers for glaucoma: From the lab to the clinic Eye 2017 31 225 231 10.1038/eye.2016.300 28085137
19. Hondur G. Göktas E. Yang X. Al-Aswad L. Auran J.D. Blumberg D.M. Cioffi G.A. Liebmann J.M. Suh L.H. Trief D. Oxidative stress-related molecular biomarker candidates for glaucoma Investig. Ophthalmol. Vis. Sci. 2017 58 4078 4088 10.1167/iovs.17-22242 28820925
20. Beykin G. Goldberg J.L. Molecular biomarkers for glaucoma Curr. Ophthalmol. Rep. 2019 7 171 176 10.1007/s40135-019-00213-0 33133776
21. Biomarkers Definitions Working Group Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework Clin. Pharmacol. Ther. 2001 69 89 95 10.1067/mcp.2001.113989 11240971
22. Strimbu K. Tavel J.A. What are biomarkers? Curr. Opin. HIV AIDS 2010 5 463 466 10.1097/COH.0b013e32833ed177 20978388
23. Tezel G. Thornton I.L. Tong M.G. Luo C. Yang X. Cai J. Powell D.W. Soltau J.B. Liebmann J.M. Ritch R. Immunoproteomic analysis of potential serum biomarker candidates in human glaucoma Invest. Ophthalmol. Vis. Sci. 2012 53 8222 8231 10.1167/iovs.12-10076 23150628
24. Damodaran S. Amino Acids, Peptides, and Proteins Fennema’s Food Chemistry 4th ed. Damodaran S. Parkin K.L. CRC Press/Taylor & Francis Boca Raton, FL, USA 2008 425 439
25. Lin Z. Huang S. Yu H. Sun J. Huang P. Zhong Y. Analysis of plasma hydrogen sulfide, homocysteine, and L-cysteine in open-angle flaucoma patients J. Ocul. Pharmacol. Ther. 2020 36 649 657 10.1089/jop.2020.0023 32493106
26. Lee W.J. Na K.I. Kim Y.K. Jeoung J.W. Park K.H. Diagnostic ability of wide-field retinal nerve fiber layer maps using swept-source optical coherence tomography for detection of preperimetric and early perimetric glaucoma J. Glaucoma 2017 26 577 585 10.1097/IJG.0000000000000662 28368998
27. Leibovitzh H. Cohen E. Levi A. Kramer M. Shochat T. Goldberg E. Krause I. Relationship between homocysteine and intraocular pressure in men and women: A population-based study Medicine 2016 95 e4858 10.1097/MD.0000000000004858 27661027
28. López-Riquelme N. Villalba C. Tormo C. Belmonte A. Fernandez C. Torralba G. Hernández F. Endothelin-1 levels and biomarkers of oxidative stress in glaucoma patients Int. Ophthalmol. 2015 35 527 532 10.1007/s10792-014-9979-8 25079761
29. Oddone F. Roberti G. Micera A. Busanello A. Bonini S. Quaranta L. Agnifili L. Manni G. Exploring serum levels of brain derived neurotrophic factor and nerve frowth factor across glaucoma stages PLoS ONE 2017 12 e0168565 10.1371/journal.pone.0168565 28068360
30. Ghaffariyeh A. Honarpisheh N. Heidari M.H. Puyan S. Abasov F. Brain-derived neurotrophic factor as a biomarker in primary open-angle glaucoma Optom. Vis. Sci. 2011 88 80 85 10.1097/OPX.0b013e3181fc329f 21076359
31. Ghaffariyeh A. Honarpisheh N. Shakiba Y. Puyan S. Chamacham T. Zahedi F. Zarrineghbal M. Brain-derived neurotrophic factor in patients with normal-tension glaucoma Optometry 2009 80 635 638 10.1016/j.optm.2008.09.014 19861219
32. Baumane K. Ranka R. Laganovska G. Association of NT-proANP level in plasma and humor aqueous with primary open-angle glaucoma Curr. Eye Res. 2017 42 233 236 10.1080/02713683.2016.1180397 27723368
33. Javadiyan S. Burdon K.P. Whiting M.J. Abhary S. Straga T. Hewitt A.W. Mills R.A. Craig J.E. Elevation of serum asymmetrical and symmetrical dimethylarginine in patients with advanced glaucoma Investig. Ophthalmol. Vis. Sci. 2012 53 1923 1927 10.1167/iovs.11-8420 22395885
34. Gye H.J. Kim J.M. Yoo C. Shim S.H. Won Y.S. Sung K.C. Lee M.Y. Park K.H. Relationship between high serum ferritin level and glaucoma in a South Korean population: The Kangbuk Samsung health study Br. J. Ophthalmol. 2016 100 1703 1707 10.1136/bjophthalmol-2015-307678 27030280
35. Lin S.C. Wang S.Y. Yoo C. Singh K. Lin S.C. Association between serum ferritin and glaucoma in the South Korean population JAMA Ophthalmol. 2014 132 1414 1420 10.1001/jamaophthalmol.2014.2876 25171442
36. González-Iglesias H. Álvarez L. García M. Escribano J. Rodríguez-Calvo P.P. Fernández-Vega L. Coca-Prados M. Comparative proteomic study in serum of patients with primary open-angle glaucoma and pseudoexfoliation glaucoma J. Proteom. 2014 98 65 78 10.1016/j.jprot.2013.12.006
37. Wang J. Fu M. Liu K. Wang N. Zhang Z. Zhou M. Xu X. Matricellular proteins play a potential role in acute primary angle closure Curr. Eye Res. 2018 43 771 777 10.1080/02713683.2018.1449222 29558210
38. Farkas R.H. Chowers I. Hackam A.S. Kageyama M. Nickells R.W. Otteson D.C. Duh E.J. Wang C. Valenta D.F. Gunatilaka T.L. Increased expression of iron-regulating genes in monkey and human glaucoma Invest. Ophthalmol. Vis. Sci. 2004 45 1410 1417 10.1167/iovs.03-0872 15111596
39. Wiesmann C. de Vos A.M. Nerve growth factor: Structure and function Cell Mol Life Sci. 2001 58 748 759 10.1007/PL00000898 11437236
40. Binder D.K. Scharfman H.E. Brain-derived neurotrophic factor Growth Factors 2004 22 123 131 10.1080/08977190410001723308 15518235
41. Skaper S.D. The neurotrophin family of neurotrophic factors: An overview Methods Mol. Biol. 2012 846 1 12 22367796
42. Wu G. Amino Acids: Biochemistry and Nutrition 1st ed. CRC Press Boca Raton, FL, USA 2013
43. Blom H.J. Smulders Y. Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects J. Inherit. Metab. Dis. 2011 34 75 81 10.1007/s10545-010-9177-4 20814827
44. Ye S. Chang Y. Kim C.W. Kwon M.J. Choi Y. Ahn J. Kim J.M. Kim H.S. Shin H. Ryu S. Intraocular pressure and coronary artery calcification in asymptomatic men and women Br. J. Ophthalmol. 2015 99 932 936 10.1136/bjophthalmol-2014-305925 25583282
45. Stow L.R. Jacobs M.E. Wingo C.S. Cain B.D. Endothelin-1 gene regulation FASEB J. 2011 25 16 28 10.1096/fj.10-161612 20837776
46. Ludwig R.J. Vanhoorelbeke K. Leypoldt F. Kaya Z. Bieber K. McLachlan S.M. Komorowski L. Luo J. Cabral-Marques O. Hammers C.M. Mechanisms of autoantibody-induced pathology Front. Immunol. 2017 8 603 10.3389/fimmu.2017.00603 28620373
47. Grus F.H. Joachim S.C. Bruns K. Lackner K.J. Pfeiffer N. Wax M.B. Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States Invest. Ophthalmol. Vis. Sci. 2006 47 968 976 10.1167/iovs.05-0685 16505031
48. Gramlich O.W. Bell K. von Thun Und Hohenstein-Blaul N. Wilding C. Beck S. Pfeiffer N. Grus F.H. Autoimmune biomarkers in glaucoma patients Curr. Opin. Pharmacol. 2013 13 90 97 10.1016/j.coph.2012.09.005 23031798
49. Beutgen V.M. Perumal N. Pfeiffer N. Grus F.H. Autoantibody biomarker discovery in primary open angle glaucoma using serological proteome analysis (SERPA) Front. Immunol. 2019 10 381 10.3389/fimmu.2019.00381 30899261
50. Joachim S.C. Pfeiffer N. Grus F.H. Autoantibodies in patients with glaucoma: A comparison of IgG serum antibodies against retinal, optic nerve, and optic nerve head antigens Graefes Arch. Clin. Exp. Ophthalmol. 2005 243 817 823 10.1007/s00417-004-1094-5 15834611
51. Joachim S.C. Wuenschig D. Pfeiffer N. Grus F.H. IgG antibody patterns in aqueous humor of patients with primary open angle glaucoma and pseudoexfoliation glaucoma Mol. Vis. 2007 13 1573 1579 17893658
52. Joachim S.C. Bruns K. Lackner K.J. Pfeiffer N. Grus F.H. Antibodies to alpha B-crystallin, vimentin, and heat shock protein 70 in aqueous humor of patients with normal tension glaucoma and IgG antibody patterns against retinal antigen in aqueous humor Curr. Eye Res. 2007 32 501 509 10.1080/02713680701375183 17612966
53. Schmelter C. Perumal N. Funke S. Bell K. Pfeiffer N. Grus F.H. Peptides of the variable IgG domain as potential biomarker candidates in primary open-angle glaucoma (POAG) Hum. Mol. Genet. 2017 26 4451 4464 10.1093/hmg/ddx332 29036575
54. Li S. Zhang H. Shao M. Li Y. Song Y. Sun X. Cao W. Association between 17-β-estradiol and interleukin-8 and visual field progression in postmenopausal omen with primary angle closure glaucoma Am. J. Ophthalmol. 2020 217 55 67 10.1016/j.ajo.2020.04.033 32360861
55. Gupta D. Wen J.C. Huebner J.L. Stinnett S. Kraus V.B. Tseng H.C. Walsh M. Cytokine biomarkers in tear film for primary open-angle glaucoma Clin. Ophthalmol. 2017 11 411 416 10.2147/OPTH.S125364 28260854
56. Paschalis E.I. Taniguchi E.V. Chodosh J. Pasquale L.R. Colby K. Dohlman C.H. Shen L.Q. Blood levels of tumor necrosis factor alpha and its type 2 receptor are elevated in patients with Boston Type I Keratoprosthesis Curr. Eye Res. 2019 44 599 606 10.1080/02713683.2019.1568500 30632412
57. Kondkar A.A. Sultan T. Almobarak F.A. Kalantan H. Al-Obeidan S.A. Abu-Amero K.K. Association of increased levels of plasma tumor necrosis factor alpha with primary open-angle glaucoma Clin. Ophthalmol. 2018 12 701 706 10.2147/OPTH.S162999 29695893
58. Kondkar A.A. Azad T.A. Almobarak F.A. Kalantan H. Al-Obeidan S.A. Abu-Amero K.K. Elevated levels of plasma tumor necrosis factor alpha in patients with pseudoexfoliation glaucoma Clin. Ophthalmol. 2018 12 153 159 10.2147/OPTH.S155168 29398902
59. Mohammadi A. Amooeian V.G. Rashidi E. Dysfunction in brain-derived neurotrophic factor signaling pathway and susceptibility to schizophrenia, Parkinson’s and Alzheimer’s diseases Curr. Gene Ther. 2018 18 45 63 10.2174/1566523218666180302163029 29512462
60. Arvat E. Broglio F. Ghigo E. Insulin-like growth factor I: Implications in aging Drugs Aging 2000 16 29 40 10.2165/00002512-200016010-00003 10733262
61. Puche J.E. Castilla-Cortázar I. Human conditions of insulin-like growth factor-I (IGF-I) deficiency J. Transl. Med. 2012 10 224 10.1186/1479-5876-10-224 23148873
62. Ferreira S.T. Brain insulin, insulin-like growth factor 1 and glucagon-like peptide 1 signalling in Alzheimer’s disease J. Neuroendocrinol. 2021 33 e12959 10.1111/jne.12959 33739563
63. Dogan A.S. Kabatas N. Erden G. Celikay O. Arzuhal A.E. Gurdal C. Serum insulin-like growth factor-1 levels in patients with pseudoexfoliation syndrome and glaucoma Int. Ophthalmol. 2017 37 371 375 10.1007/s10792-016-0271-y 27245680
64. Schlötzer-Schrehardt U. Naumann G.O. Ocular and systemic pseudoexfoliation syndrome Am. J. Ophthalmol. 2006 141 921 937 10.1016/j.ajo.2006.01.047 16678509
65. Ekström C. Kilander L. Pseudoexfoliation and Alzheimer’s disease: A population-based 30-year follow-up study Acta Ophthalmol. 2014 92 355 358 10.1111/aos.12184 23879292
66. Guo T. Guo L. Fan Y. Fang L. Wei J. Tan Y. Chen Y. Fan X. Aqueous humor levels of TGFβ2 and SFRP1 in different types of glaucoma BMC Ophthalmol. 2019 19 170 10.1186/s12886-019-1183-1 31382918
67. Newman-Casey P.A. Talwar N. Nan B. Musch D.C. Pasquale L.R. Stein J.D. The potential association between postmenopausal hormone use and primary open-angle glaucoma JAMA Ophthalmol. 2014 132 298 303 10.1001/jamaophthalmol.2013.7618 24481323
68. Lee S.S. Sanfilippo P.G. Yazar S. Pennell C.E. Hewitt A.W. Wang C.A. Martin W.N. Mackey D.A. Do levels of stress markers influence the retinal nerve fiber layer thickness in young adults? J. Glaucoma 2020 29 587 592 10.1097/IJG.0000000000001511 32287148
69. Canizales L. Rodriguez L. Rivera C. Martinez A. Mendez F. Castillo A. Low-level expression of SOD1 in peripheral blood samples of patients diagnosed with primary open-angle glaucoma Biomark. Med. 2016 10 1218 1223 10.2217/bmm-2016-0167 27924632
70. Li S. Shao M. Li Y. Li X. Wan Y. Sun X. Cao W. Relationship between oxidative stress biomarkers and visual field progression in patients with primary angle closure glaucoma Oxid. Med. Cell Longev. 2020 2020 2701539 10.1155/2020/2701539 32831992
71. Glantzounis G.K. Tsimoyiannis E.C. Kappas A.M. Galaris D.A. Uric acid and oxidative stress Curr. Pharm. Des. 2005 11 4145 4151 10.2174/138161205774913255 16375736
72. Li S. Shao M. Li D. Tang B. Cao W. Sun X. Association of serum uric acid levels with primary open-angle glaucoma: A 5-year case-control study Acta Ophthalmol. 2019 97 356 363 10.1111/aos.13789
73. Li S. Shao M. Tang B. Zhang A. Cao W. Sun X. The association between serum uric acid and glaucoma severity in primary angle closure glaucoma: A retrospective case-control study Oncotarget 2017 8 2816 2824 10.18632/oncotarget.13745 27926530
74. Good D.M. Thongboonkerd V. Novak J. Bascands J.L. Schanstra J.P. Coon J.J. Dominiczak A. Mischak H. Body fluid proteomics for biomarker discovery: Lessons from the past hold the key to success in the future J. Proteom. Res. 2007 6 4549 4555 10.1021/pr070529w 17970587
75. Thongboonkerd V. Proteomics of Human Body Fluids. Principles, Methods, and Applications 1st ed. Humana Press Totowa, NJ, USA 2007
76. Zhou L. Beuerman R.W. Foo Y. Liu S. Ang L.P. Tan D.T. Characterisation of human tear proteins using high-resolution mass spectrometry Ann. Acad. Med. Singap. 2006 35 400 407 16865190
77. Zhou L. Zhao S.Z. Koh S.K. Chen L. Vaz C. Tanavde V. Li X.R. Beuerman R.W. In-depth analysis of the human tear proteome J. Proteom. 2012 75 3877 3885 10.1016/j.jprot.2012.04.053
78. Pan C.W. Ke C. Chen Q. Tao Y.J. Zha X. Zhang Y.P. Zhong H. Differential metabolic markers associated with primary open-angle glaucoma and cataract in human aqueous humor BMC Ophthalmol. 2020 20 183 10.1186/s12886-020-01452-7 32375707
79. Celis J.E. Gromov P. 2D protein electrophoresis: Can it be perfected? Curr. Opin. Biotechnol. 1999 10 16 21 10.1016/S0958-1669(99)80004-4 10047502
80. Boehm N. Wolters D. Thiel U. Lossbrand U. Wiegel N. Pfeiffer N. Grus F.H. New insights into autoantibody profiles from immune privileged sites in the eye: A glaucoma study Brain Behav. Immun. 2012 26 96 102 10.1016/j.bbi.2011.07.241 21843631
81. Hosseini S. Vázquez-Villegas P. Rito-Palomares M. Martinez-Chapa S.O. Advantages, disadvantages and modifications of conventional ELISA Enzyme-Linked Immunosorbent Assay (ELISA) 1st ed. Hosseini S. Vázquez-Villegas P. Rito-Palomares M. Martinez-Chapa S.O. Springer Singapore 2018 67 115
82. Aretz I. Meierhofer D. Advantages and pitfalls of mass spectrometry based metabolome profiling in systems biology Int. J. Mol. Sci. 2016 17 632 10.3390/ijms17050632
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.